NEW YORK (GenomeWeb News) – Sigma-Aldrich's board of directors this week declared a quarterly cash dividend of $.16 per share. The dividend will be payable on Sep. 15 to shareholders of record on Sep. 1.
Thermo Fisher Scientific is shutting down its East Providence, RI, facility next June, a spokesman for the company confirmed today. The firm said that it is discontinuing operations at its clinical diagnostics facility there and transferring production to other Thermo Fisher locations. The facility manufactures reagents, calibrators, and controls for the medical diagnostics industry. The spokesman did not say how many jobs would be lost as a result of the closure.
BioServe and NGC Medical said this week that they have opened BioServe-Europe in Milan, Italy. The facility will provide customers with a variety of molecular services including genetic tests, high-throughput genotyping, and DNA and RNA extractions. NGC began collaborating with BioServe in April to offer CLIA-certified personalized genomic services.
Myconostica said that its lead products, MycAssay Aspergillus and MycAssay Pneumocystis, have received the CE Mark for running on the Roche LightCycler 2.0 and Stratagene Mx3000 series platforms. The firm's assays were already CE Marked for use on the Cepheid Smartcycler and Applied Biosystems' ABI 7500, the Manchester, UK-based firm said.
Cord Blood America said this week that it has signed a deal with the DNA Shop to offer Cord Blood America's DNA testing services for newborns to determine whether they may be predisposed for certain diseases. According to a spokesman for Cord Blood America, the partnership is strictly for the sale of the predisposition testing service, and the two firms are not disclosing its terms.